Home
/
Korro Bio, Inc.
/
Financials
/
Quarterly
Korro Bio, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Korro Bio, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.09M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$1.46M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$2.55M
May 7, 2025
Q3
2025
Sep 30, 2024
$0
Nov 12, 2025
Q2
2025
Jun 30, 2024
$0
Aug 12, 2025
Q1
2025
Mar 31, 2024
$0
May 7, 2025
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2022
Sep 30, 2022
$0
Nov 8, 2022
Q2
2022
Jun 30, 2022
$0
Aug 9, 2022
Q1
2022
Mar 31, 2022
$0
May 4, 2022
Q3
2022
Sep 30, 2021
$0
Nov 8, 2022
Q2
2022
Jun 30, 2021
$9.42M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$4.65M
May 4, 2022
Q3
2021
Sep 30, 2020
$11.25M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$8.52M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$7.26M
May 13, 2021
Q3
2020
Sep 30, 2019
$24.24M
Nov 16, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($18.06M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($25.77M)
Aug 12, 2025
Q3
2025
Jun 30, 2025
($25.77M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($23.39M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($23.39M)
May 7, 2025
Q3
2025
Mar 31, 2025
($23.39M)
Nov 12, 2025
Q3
2025
Sep 30, 2024
($21.00M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($21.83M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($21.83M)
Aug 12, 2025
Q2
2025
Mar 31, 2024
($19.56M)
Aug 12, 2025
Q3
2025
Mar 31, 2024
($19.56M)
Nov 12, 2025
Q1
2025
Mar 31, 2024
($19.56M)
May 7, 2025
Q3
2024
Sep 30, 2023
($18.49M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($17.65M)
Aug 13, 2024
Q3
2024
Jun 30, 2023
($17.65M)
Nov 12, 2024
Q1
2024
Mar 31, 2023
($19.61M)
May 14, 2024
Q2
2024
Mar 31, 2023
($19.61M)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($19.61M)
Nov 12, 2024
Q3
2023
Sep 30, 2022
($19.55M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($21.29M)
Aug 10, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($19.24M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($27.20M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($25.02M)
May 7, 2025
Q3
2025
Sep 30, 2024
($23.29M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($24.13M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($21.45M)
May 7, 2025
Q3
2024
Sep 30, 2023
($19.15M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($18.41M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($20.09M)
May 14, 2024
Q3
2023
Sep 30, 2022
($20.28M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($21.27M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($23.26M)
May 12, 2023
Q3
2022
Sep 30, 2021
($24.99M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($17.48M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($20.20M)
May 4, 2022
Q3
2021
Sep 30, 2020
($5.42M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($6.20M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($5.66M)
May 13, 2021
Q3
2020
Sep 30, 2019
($1.25M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($7.02M)
Aug 12, 2020